Lupkynis (voclosporin) - Aurinia Pharma
Blood pressure remains elevated in patients initiating voclosporin with low baseline blood pressure: evidence from patients in routine clinical care (ACR Convergence 2025) - Sep 15, 2025 - Abstract #0655; Pres time: Oct 26, 2025; 10:30 AM - 12:30 PM; Location: Hall F1; In Person; ">50% of patients using voclosporin had a MCID in the first year of use. Increases tend to occur in the first 3 months of use and on average were larger for patients with normal baseline BPs. In contrast to findings reported from RCTs, BP increases for patients with normal baseline BPs were persistent over 12 months." 
Clinical • Cardiovascular • Glomerulonephritis • Hypertension • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Rheumatology
https://eppro02.ativ.me/web/page.php?page=IntHtml&project=ACR25&id=3187259
 
Eric Roberts1; gabriela Schmajuk2; Jinoos Yazdany3
 
Sep 15, 2025
 
Prev Next